Liminal BioSciences Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with liver, respiratory and kidney disease, provided a corporate update and outlined its key corporate and R&D priorities for 2020.
January 13, 2020
· 5 min read